Relationship between single nucleotide polymorphisms in leptin, IL6 and adiponectin genes and their circulating product in morbidly obese subjects before and after gastric banding surgery

Obesity Surgery

Volumn 15, Issue 1, 2005, Pages 11-23

  Poitou, Christine ^a,b   Lacorte, Jean Marc ^b   Coupaye, Muriel ^a   Bertrais, Sandrine ^a   Bedel, Jean François ^b   Lafon, Nicolas ^b   Bouillot, Jean Luc ^a   Galan, Pilar ^a   Borson Chazot, Françoise ^c   Basdevant, Arnaud ^a   Coussieu, Christiane ^b   Clément, Karine ^a  

^a INSERM   (France)

^b HÔTEL DIEU   (France)

^c Hopital Neuro Cardiologique   (France)

Author keywords

Adiponectin; Adiposity signal; Association study; IL6; Laparoscopic gastric banding; Leptin; Morbid obesity; Weight homeostasis

Indexed keywords

ADENINE; ADIPONECTIN; CYTOSINE; GUANINE; INTERLEUKIN 6; LEPTIN;

ADIPOSE TISSUE; ADULT; ARTICLE; BODY MASS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENERGY BALANCE; ENERGY METABOLISM; FEEDBACK SYSTEM; FEMALE; GASTRIC BANDING; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; WEIGHT GAIN; WEIGHT REDUCTION;

ADIPONECTIN; ADULT; BODY MASS INDEX; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; ENERGY METABOLISM; FEMALE; GASTROPLASTY; GENETIC MARKERS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-6; LEPTIN; MALE; MIDDLE AGED; OBESITY, MORBID; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; PROBABILITY; PROGNOSIS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 13444252979     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1381/0960892052993431     Document Type: Article

References (71)

1. Mohamed-Ali V, Pinkney JH, Coppack SW. Adipose tissue as an endocrine and paracrine organ. Int J Obes 1998; 22: 1145-58.
2. Ahima RS, Flier JS. Adipose tissue as an endocrine organ. Trends Endocrinol Metab 2000; 11: 327-32.
3. Trayhurn P, Beattie JH. Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc Nutr Soc 2001; 60: 329-39.
4. Frayn KN, Karpe F, Fielding BA et al. Integrative physiology of human adipose tissue. Int J Obes 2003; 27: 875-88.
5. Lyon CJ, Law RE, Hsueh WA. Minireview: adiposity, inflammation, and atherogenesis. Endocrinology 2003; 144: 2195-200.
6. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004; 89: 2548-56.
7. Schwartz MW, Woods SC, Porte D Jr et al. Central nervous system control of food intake. Nature 2000; 404: 661-71.
8. Schwartz MW. Brain pathways controlling food intake and body weight. Exp Biol Med (Maywood) 2001; 226: 978-81.
9. Woods SC, Seeley RJ. Adiposity signals and the control of energy homeostasis. Nutrition 2000; 16: 894-902.
10. Porte D Jr, Baskin DG, Schwartz MW. Leptin and insulin action in the central nervous system. Nutr Rev 2002; 60: S20-29; discussion S68-84, 85-27.
11. Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature 1998; 395: 763-70.
12. Bjorbaek C, Kahn BB. Leptin signaling in the central nervous system and the periphery. Recent Prog Horm Res 2004; 59: 305-31.
13. Ahima RS, Osei SY. Leptin signaling. Physiol Behav 2004; 81: 223-41.
14. Leibel RL. The role of leptin in the control of body weight. Nutr Rev 2002; 60: S15-19; discussion S68-84, 85-17.
15. Niswender KD, Schwartz MW. Insulin and leptin revisited: adiposity signals with overlapping physiological and intracellular signaling capabilities. Front Neuroendocrinol 2003; 24: 1-10.
16. Rushing PA. Central amylin signaling and the regulation of energy homeostasis. Curr Pharm Des 2003; 9: 819-25.
17. Plata-Salaman CR. Cytokines and feeding. Int J Obes 2001; 25(Suppl 5): S48-52.
18. Bastard JP, Jardel C, Bruckert E et al. Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J Clin Endocrinol Metab 2000; 85: 3338-42.
19. Mohamed-Ali V, Goodrick S, Rawesh A et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 1997; 82: 4196-200.
20. Wallenius K, Wallenius V, Sunter D et al. Intracerebroventricular interleukin-6 treatment decreases body fat in rats. Biochem Biophys Res Commun 2002; 293: 560-5.
21. Wallenius V, Wallenius K, Ahren B et al. Interleukin-6-deficient mice develop mature-onset obesity. Nat Med 2002; 8: 75-9.
22. Scherer PE, Williams S, Fogliano M et al. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995; 270: 26746-9.
23. Hu E, Liang P, Spiegelman BM. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 1996; 271: 10697-703.
24. Maeda K, Okubo K, Shimomura I et al. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem Biophys Res Commun 1996; 221: 286-9.
25. Arita Y, Kihara S, Ouchi N et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999; 257: 79-83.
26. Pajvani UB, Scherer PE. Adiponectin: systemic contributor to insulin sensitivity. Curr Diab Rep 2003; 3: 207-13.
27. Matsuzawa Y, Funahashi T, Kihara S et al. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 2004; 24: 29-33.
28. Havel PJ. Update on adipocyte hormones: regulation of energy balance and carbohydrate/lipid metabolism. Diabetes 2004; 53 (Suppl 1): S143-151.
29. Qi Y, Takahashi N, Hileman SM et al. Adiponectin acts in the brain to decrease body weight. Nat Med 2004; 10: 524-9.
30. Clement K, Boutin P, Froguel P. Genetics of obesity. Am J Pharmacogenomics 2002; 2: 177-87.
31. Cancello R, Tounian A, Poitou C et al. Adiposity signals, genetic and body weight regulation in humans. Diabetes Metab 2004; 30: 215-27.
32. Ohshiro Y, Ueda K, Nishi M et al. A polymorphic marker in the leptin gene associated with Japanese morbid obesity. J Mol Med 2000; 78: 516-20.
33. Mammes O, Betoulle D, Aubert R et al. Association of the G-2548A polymorphism in the 5′ region of the LEP gene with overweight. Ann Hum Genet 2000; 64: 391-4.
34. Huang QY, Shen H, Deng HY et al. Linkage and association of the CA repeat polymorphism of the IL6 gene, obesity-related phenotypes, and bone mineral density (BMD) in two independent Caucasian populations. J Hum Genet 2003; 48: 430-7.
35. Kubaszek A, Pihlajamaki J, Punnonen K et al. The C-174G promoter polymorphism of the IL-6 gene affects energy expenditure and insulin sensitivity. Diabetes 2003; 52: 558-61.
36. Berthier MT, Paradis AM, Tchernof A et al. The interleukin 6-174G/C polymorphism is associated with indices of obesity in men. J Hum Genet 2003; 48: 14-9.
37. Fernandez-Real JM, Broch M, Vendrell J et al. Interleukin-6 gene polymorphism and insulin sensitivity. Diabetes 2000; 49: 517-20.
38. Vozarova B, Fernandez-Real JM, Knowler WC et al. The interleukin-6 (-174) G/C promoter polymorphism is associated with type-2 diabetes mellitus in Native Americans and Caucasians. Hum Genet 2003; 112: 409-13.
39. Yang WS, Tsou PL, Lee WJ et al. Allele-specific differential expression of a common adiponectin gene polymorphism related to obesity. J Mol Med 2003; 81: 428-34.
40. Ukkola O, Ravussin E, Jacobson P et al. Mutations in the adiponectin gene in lean and obese subjects from the Swedish obese subjects cohort. Metabolism 2003; 52: 881-4.
41. Vasseur F, Helbecque N, Dina C et al. Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians. Hum Mol Genet 2002; 11: 2607-14.
42. Menzaghi C, Ercolino T, Di Paola R et al. A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome. Diabetes 2002; 51: 2306-12.
43. Hager J, Clement K, Francke S et al. A polymorphism in the 5′ untranslated region of the human ob gene is associated with low leptin levels. Int J Obes 1998; 22: 200-5.
44. Hoffstedt J, Eriksson P, Mottagui-Tabar S et al. A polymorphism in the leptin promoter region (-2548 G/A) influences gene expression and adipose tissue secretion of leptin. Horm Metab Res 2002; 34: 355-9.
45. Fishman D, Faulds G, Jeffery R et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998; 102: 1369-76.
46. Villuendas G, San Millan JL, Sancho J et al. The -597 G→A and -174 G→C polymorphisms in the promoter of the IL-6 gene are associated with hyperandrogenism. J Clin Endocrinol Metab 2002; 87: 1134-41.
47. Endler G, Marsik C, Joukhadar C et al. The interleukin-6 G(-174)C promoter polymorphism does not determine plasma interleukin-6 concentrations in experimental endotoxemia in humans. Clin Chem 2004; 50: 195-200.
48. Fumeron F, Aubert R, Siddiq A et al. Adiponectin gene polymorphisms and adiponectin levels are independently associated with the development of hyperglycemia during a 3-year period: the epidemiologic data on the insulin resistance syndrome prospective study. Diabetes 2004; 53: 1150-7.
49. Hereberg S, Preziosi P, Briancon S et al. A primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers in a general population: the SU.VI.MAX study - design, methods, and participant characteristics. Supplementation en VItamines et Mineraux AntioXydants. Control Clin Trials 1998; 19: 336-51.
50. Kopp HP, Kopp CW, Festa A et al. Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients. Arterioscler Thromb Vasc Biol 2003; 23: 1042-7.
51. Faraj M, Havel PJ, Phelis S et al. Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab 2003; 88: 1594-602.
52. Holdstock C, Engstrom BE, Ohrvall M et al. Ghrelin and adipose tissue regulatory peptides: effect of gastric bypass surgery in obese humans. J Clin Endocrinol Metab 2003; 88: 3177-83.
53. Yang WS, Lee WJ, Funahashi T et al. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 2001; 86: 3815-9.
54. Vendrell J, Broch M, Vilarrasa N et al. Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity. Obes Res 2004; 12: 962-71.
55. Uzun H, Zengin K, Taskin M et al. Changes in leptin, plasminogen activator factor and oxidative stress in morbidly obese patients following open and laparoscopic Swedish adjustable gastric banding. Obes Surg 2004; 14: 659-65.
56. Hanusch-Enserer U, Cauza E, Spak M et al. Improvement of insulin resistance and early atherosclerosis in patients after gastric banding. Obes Res 2004; 12: 284-91.
57. Weyer C, Funahashi T, Tanaka S et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001; 86: 1930-5.
58. Bruun JM, Lihn AS, Verdich C et al. Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans. Am J Physiol Endocrinol Metab 2003; 285: E527-533.
59. Esposito K, Pontillo A, Di Palo C et al. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA 2003; 289: 1799-804.
60. Valsamakis G, McTernan PG, Chetty R et al. Modest weight loss and reduction in waist circumference after medical treatment are associated with favorable changes in serum adipocytokines. Metabolism 2004; 53: 430-4.
61. Le Stunff C, Le Bihan C, Schork NJ et al. A common promoter variant of the leptin gene is associated with changes in the relationship between serum leptin and fat mass in obese girls. Diabetes 2000; 49: 2196-200.
62. Lindsay RS, Funahashi T, Krakoff J et al. Genomewide linkage analysis of serum adiponectin in the Pima Indian population. Diabetes 2003; 52: 2419-25.
63. Comuzzie AG, Funahashi T, Sonnenberg G et al. The genetic basis of plasma variation in adiponectin, a global endophenotype for obesity and the metabolic syndrome. J Clin Endocrinol Metab 2001; 86: 4321-5.
64. Brull DJ, Montgomery HE, Sanders J et al. Interleukin-6 gene -174g>c and -572g>c promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. Arterioscler Thromb Vasc Biol 2001; 21: 1458-63.
65. Cottam DR, Mattar SG, Barinas-Mitchell E et al. The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: implications and effects of weight loss. Obes Surg 2004; 14: 589-600.
66. Hanusch-Enserer U, Cauza E, Spak M et al. Acute-phase response and immunological markers in morbid obese patients and patients following adjustable gastric banding. Int J Obes 2003; 27: 355-61.
67. Laimer M, Ebenbichler CF, Kaser S et al. Markers of chronic inflammation and obesity: a prospective study on the reversibility of this association in middle-aged women undergoing weight loss by surgical intervention. Int J Obes 2002; 26: 659-62.
68. Heilbronn LK, Noakes M, Clifton PM. Energy restriction and weight loss on very-low-fat diets reduce C-reactive protein concentrations in obese, healthy women. Arterioscler Thromb Vasc Biol 2001; 21: 968-70.
69. Ziccardi P, Nappo F, Giugliano G et al. Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 2002; 105: 804-9.
70. Clement K, Viguerie N, Poitou C et al. Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects. FASEB J 2004; 18: 1657-69.
71. Farooqi IS, Keogh JM, Kamath S et al. Partial leptin deficiency and human adiposity. Nature 2001; 414: 34-5.